Aug 11 (Reuters) - Parnell Pharmaceuticals Holdings Ltd PARN.O :
* Announces financial results for the six-month period ended June 30, 2015
* Sales of reproductive hormones in the US are expected to maintain strong
growth in the second half of 2015 compared to 2014
* Says expect to file the full registration dossiers for zydax for use in dogs,
in the US and EU in 2015
* Says net loss per weighted-average share was $0.22 for the six-months ended
June 30, 2015
* All figures in aud$
* Source text for Eikon ID:nGNXVEFAPa
* Further company coverage PARN.O
((Bengaluru Newsroom; +1 646 223 8780))